Concepedia

Leslie Baitinger

LB

Statistics

Publications

7

Citations

749

H-Index

7

Active since

2000

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

Institute for Asthma and Allergy

University of Colorado Denver

National Jewish Health

Leslie Baitinger is an author at Research Triangle Park Foundation specializing in pharmacology, asthma management, and pharmacy.

Publications per year

2000–2006

7

Publications

7

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial

Mani S. Kavuru, Julian Melamed, Gary N. Gross et al. · Journal of Allergy and Clinical Immunology · 2000 · 240 citations · Full text

, , +15

Combined Salmeterol 50 μ g and Fluticasone Propionate 250 μ g in the Diskus Device for the Treatment of Asthma

Gail Shapiro, William R. Lumry, James Wolfe et al. · American Journal of Respiratory and Critical Care Medicine · 2000 · 201 citations

, , +13

Salmeterol response is not affected by β2-adrenergic receptor genotype in subjects with persistent asthma

Eugene R. Bleecker, Steve Yancey, Leslie Baitinger et al. · Journal of Allergy and Clinical Immunology · 2006 · 154 citations · Full text

, , +7

Efficacy and Safety of Fluticasone Propionate/Salmeterol HFA 134A MDI in Patients with Mild‐to‐Moderate Persistent Asthma

David S. Pearlman, David B. Peden, John J. Condemi et al. · Journal of Asthma · 2004 · 50 citations

, , +17

Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting β2-agonists

John Murray, Richard R. Rosenthal, Laura L. Somerville et al. · Annals of Allergy Asthma & Immunology · 2004 · 39 citations

, , +7

1–5 of 7